University of Nottingham
  • Print


HOME is an global initiative of patients, healthcare professionals, journal editors, regulatory authorities and the pharmaceutical industry.

Aim: To develop a consensus-based core outcome set (COS) for clinical trials and clinical practice.The core outcome set is the MINIMUM that should be measured in ALL clinical trials.

HOME Core Outcome Set (for clinical trials)

  • Clinical signs (Core Outcome Instrument: EASI)
  • Symptoms (Core Outcome Instrument: POEM)
  • Long term control
  • Quality of Life


Membership of HOME is free and open to anyone with an interest in atopic eczema outcomes. 

Email us Follow us

HOME logo

Next consensus meeting

If you wish to be placed on a waiting list, please email us.

The next HOME meeting will be Wednesday 11 April 2018, 09:00-12:00 (satellite to the ISAD 2018 in Utrecht, The Netherlands).

The focus will be on identifying valid and feasible outcome measurement instruments for atopic eczema in routine clinical practice. See our HOME VI meeting page for further information.

The core outcome set (COS) and core outcome instruments
Past and future HOME meetings
We're proud to have patients as an integral part of HOME
Articles, reviews and meeting reports from HOME
Background to the HOME initiative
Links to other core outcomes related projects

HOME - Harmonising Outcome Measures for Eczema

Centre of Evidence Based Dermatology
University of Nottingham
King's Meadow Campus
Lenton Lane, Nottingham

Telephone: +44 115 8232435
Fax: +44 115 8468618